Charles River Laboratories International (CRL) EBT Margin Growth (1y) (2010 - 2025)
Charles River Laboratories International (CRL) EBT Margin Growth (1y) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 212.96 Bn | 208.90 Bn | 8.34 Bn | 30.00 |
| 2 | Danaher | 139.30 Bn | 134.95 Bn | 3.61 Bn | 617.00 |
| 3 | Idexx Laboratories | 46.15 Bn | 45.95 Bn | 779.09 Mn | 163.00 |
| 4 | Agilent Technologies | 39.40 Bn | 37.59 Bn | 990.00 Mn | 665.00 |
| 5 | Iqvia Holdings | 38.20 Bn | 36.12 Bn | 1.44 Bn | -115.00 |
| 6 | Natera | 37.79 Bn | 36.69 Bn | 696.04 Mn | 113.00 |
| 7 | Illumina | 28.65 Bn | 27.49 Bn | 770.00 Mn | -646.00 |
| 8 | Mettler Toledo International | 28.40 Bn | 28.35 Bn | 650.22 Mn | 288.00 |
| 9 | Quest Diagnostics | 26.32 Bn | 25.69 Bn | 1.03 Bn | -37.00 |
| 10 | Charles River Laboratories International | 12.84 Bn | 12.62 Bn | 1.81 Bn | -796.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 27, 2025 | -796.00 |
| Sep 27, 2025 | -36.00 |
| Jun 28, 2025 | -474.00 |
| Mar 29, 2025 | -613.00 |
| Dec 28, 2024 | -4,222.00 |
| Sep 28, 2024 | -196.00 |
| Jun 29, 2024 | -48.00 |
| Mar 30, 2024 | -294.00 |
| Dec 30, 2023 | -168.00 |
| Sep 30, 2023 | -145.00 |
| Jul 1, 2023 | -267.00 |
| Apr 1, 2023 | 60.00 |
| Dec 31, 2022 | 419.00 |
| Sep 24, 2022 | -131.00 |
| Jun 25, 2022 | 87.00 |
| Mar 26, 2022 | 409.00 |
| Dec 25, 2021 | -372.00 |
| Sep 25, 2021 | -444.00 |
| Jun 26, 2021 | 164.00 |
| Mar 27, 2021 | 20.00 |